ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter: +11.81%
1-year: -6.13%
3-year: +68.78%
5-year: +54.42%
3-year vs S&P 500: -4.46%
5-year vs S&P 500: -19.26%
5-year top 5: +37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Filing period

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 5 of 16 rows. Rows without a quote are marked unavailable.


1	VRX	VALEANT PHARMACEUTICALS INTL COM	19.76%	-	26,959,901	$762.7M	No quote	No quote
2	SLE	SARA LEE CORP COM	15.84%	-	34,918,822	$611.43M	No quote	No quote
3	IT	GARTNER INC COM	14.44%	-	16,790,013	$557.43M	$33.20	No quote
4	BCR	C R BARD INC COM	10.96%	Add +8.6%	4,611,139	$423.16M	No quote	No quote
5	VRSN	VERISIGN INC COM	9.51%	Reduce -5.1%	11,232,069	$366.95M	$32.67	No quote
6	WSH	WILLIS GROUP HOLDINGS PUBLIC SHS	7.77%	-	8,656,910	$299.79M	No quote	No quote
7	SNA	SNAP ON INC COM	6.01%	Reduce -11.3%	4,101,780	$232.08M	$56.58	No quote
8	ALR	ALERE INC COM	4.70%	Reduce -5.1%	4,960,497	$181.55M	No quote	No quote
9	MCO	MOODYS CORP COM	4.20%	New	6,113,200	$162.24M	$26.54	No quote
10	BLUD	IMMUCOR INC COM	3.87%	-	7,540,665	$149.53M	No quote	No quote
11	NYT	NEW YORK TIMES CO CL A	1.78%	New	7,000,000	$68.6M	$9.80	No quote
12	KAR	KAR AUCTION SVCS INC COM	0.81%	-	2,258,828	$31.17M	No quote	No quote
13	ES	ENERGY SOLUTIONS INC COM	0.36%	-	2,495,218	$13.9M	No quote	No quote
16	VRSK	VERISK ANALYTICS INC CL A COM	-	Sold	0	$0	No quote	No quote
15	PLCM	POLYCOM INC COM	-	Sold	0	$0	No quote	No quote
14	ALRPRB	ALERE INC PERP PFD CONV SE	-	Sold	0	$0	No quote	No quote